Status:
RECRUITING
European TauroPace Registry - University of Schleswig-Holstein Prospective Observational Clinical Study
Lead Sponsor:
University of Kiel
Collaborating Sponsors:
University of Luebeck
Conditions:
CIED Related Infection
Eligibility:
All Genders
18+ years
Brief Summary
University of Schleswig-Holstein Campus Kiel is sponsoring the European TauroPace Registry. This investigator-initiated local, prospective, non-interventional, multi-center study includes patients und...
Detailed Description
This study is performed as an all-case investigation. The treatment is performed based on the SOPs (Appendix Study Protocol). The standard observation period is 3 months from the 1st treatment. Safety...
Eligibility Criteria
Inclusion
- Use of TauroPace™ is indicated and not contra-indicated according to its current Instructions For Use (IFU)
- Participant is eligible for a CIED related surgery procedure.
Exclusion
- Age\<18years
- Participant incapable of signing Patient Informed Consent (mentally or physically) or does not sign.
Key Trial Info
Start Date :
February 22 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 30 2030
Estimated Enrollment :
2300 Patients enrolled
Trial Details
Trial ID
NCT04735666
Start Date
February 22 2021
End Date
January 30 2030
Last Update
April 6 2025
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Landeskrankenhaus Wiener Neustadt
Wiener Neustadt, Austria, 2700
2
Louis Pradel Hospital
Lyon, Bron, France, 69500
3
Krankenhaus Landshut Achdorf
Landshut, Bavaria, Germany, 84036
4
Helios Klinik Cuxhaven
Cuxhaven, Lower Saxony, Germany, 27474